Citation Impact
Citing Papers
A Novel Subtype of the Prostacyclin Receptor Expressed in the Central Nervous System
1996 StandoutNobel
Medical-eligibility criteria for contraceptive use
2001 Standout
Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure
1996
5 Selective Inhibitors of Cyclooxygenase-2 (COT-2)
1999
Selexipag for the Treatment of Pulmonary Arterial Hypertension
2015
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
1995 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Cloning and expression of a cDNA for rat prostacyclin receptor
1994
Identification of Domains Conferring Ligand Binding Specificity to the Prostanoid Receptor
1997
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Systemic sclerosis
2017 Standout
The guanosine binding site of the Tetrahymena ribozyme
1989 StandoutNatureNobel
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
2008 Standout
PGI2-receptors and molecular mechanisms in platelets and vasculature: State of the art
1987
Induction of A 31,000-dalton stress protein by prostaglandins D2 and J2 in porcine aortic endothelial cells
1991
The effects of capsaicin, bradykinin, PGE2 and cicaprost on the discharge of articular sensory receptors in vitro
1993
In vitro characterization of prostanoid FP‐, DP‐, IP‐ and TP‐receptors on the non‐pregnant human myometrium
1992
The biology and pharmacology of PGD2
1988
Enantioselective Synthesis of Tertiary and Quaternary Stereogenic Centers: Copper/Phosphoramidite‐Catalyzed Allylic Alkylation with Organolithium Reagents
2012 StandoutNobel
Platelet Activation and Atherothrombosis
2007 Standout
Polycystic Ovary Syndrome
1995 Standout
AH6809, a prostaglandin DP‐receptor blocking drug on human platelets
1988
Contraception
2000
Biological activities and mechanisms of action of PGJ2 and related compounds: an update
1992
Deficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition
2001 StandoutNobel
Autocrine control of adipose cell differentiation by prostacyclin and PGF2α
1991
Natural Product Hybrids as New Leads for Drug Discovery
2003 Standout
Polycystic Ovary Syndrome
2005 Standout
A Novel Subtype of Prostacyclin Receptor in the Central Nervous System
1999 StandoutNobel
Prostaglandin and thromboxane biosynthesis
1991
Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors
1989
Stimulation of prostaglandin D2 receptors on human platelets by analogs of prostacyclin
1991
Molecular Cloning and Characterization of the Human Prostanoid DP Receptor
1995
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Microenvironmental regulation of metastasis
2008 Standout
Enantioselective Synthesis of All‐Carbon Quaternary Stereogenic Centers via Copper‐Catalyzed Asymmetric Allylic Alkylation of (Z)‐Allyl Bromides with Organolithium Reagents
2015 StandoutNobel
Evaluation of ZK110841 and AH6809, an agonist and an antagonist of prostaglandin DP‐receptors on human platelets, with a PGD2‐responsive cell line from bovine embryonic trachea
1990
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function
2006
A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
1995 Standout
The mechanisms of enhancement and inhibition of field stimulation responses of guinea‐pig vas deferens by prostacyclin analogues
1997
Synthesis and evaluation of geldanamycin-estradiol hybrids
1999
Guanine nucleotide sensitivity of [3H]iloprost binding to prostacyclin receptors
1991
Platelet–cancer interactions: mechanisms and pharmacology of tumour cell‐induced platelet aggregation
2004
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
2000
The classification of prostaglandin DP‐receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist
1989
Release and effects of prostaglandins in adipose tissue
1992
A Metal‐Free Transfer Hydrogenation: Organocatalytic Conjugate Reduction of α,β‐Unsaturated Aldehydes
2004 StandoutNobel
Synthesis of 7-Fluoro-2,4-methylene-17,20-dimethylprostacyclins. Novel stable prostacyclin analogs as potent anti-anginal agents
1995
E-Prostanoid-3 Receptors Mediate the Proinflammatory Actions of Prostaglandin E2 in Acute Cutaneous Inflammation
2004 StandoutNobel
Iron Catalysis in Organic Synthesis
2015 Standout
Central control of hepatic steroid metabolism and “lactogenic” receptor
1980
Organic Synthesis of Prostaglandins: Advancing Biology
1993 StandoutScienceNobel
Prostanoid Receptors: Structures, Properties, and Functions
1999 Standout
Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene.
1994
Synthesis of Heterocycles via Electrophilic Cyclization of Alkynes Containing Heteroatom
2011 Standout
Proline-specific endopeptidases from microbial sources: isolation of an enzyme from a Xanthomonas sp
1992 StandoutNobel
Copper/Iron‐Cocatalyzed Highly Selective Tandem Reactions: Efficient Approaches to Z‐γ‐Alkylidene Lactones
2009
Stereo- and regiocontrolled construction of 3-alkyl-cis-bicyclo[4.3.0]non-3-ene derivatives. An efficient synthesis of the potent homoisocarbacyclin analog
1987
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
1983 StandoutScienceNobel
Highly Stereoselective Anti SN2‘ Substitutions of (Z)-Allylic Pentafluorobenzoates with Polyfunctionalized Zinc−Copper Reagents
2003
A highly efficient synthesis of γ-halo allylic alcohols and propargylic alcohols with high optical purity. Practical method for synthesis of the prostaglandin ω-chain
1987
Flexible Syntheses of Optically Active Isocarbacyclins
1989
Hormonal inhibition of adenylate cyclase. alpha 2 Adrenergic receptors promote release of [3H]guanylylimidodiphosphate from platelet membranes.
1982 StandoutNobel
Catalytic, Asymmetric Transannular Aldolizations: Total Synthesis of (+)-Hirsutene
2008 StandoutNobel
Partial purification and characterization of post-proline cleaving enzyme:
1976
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Rapid Methylation for the Synthesis of a 11C-Labeled Tolylisocarbacyclin Imaging the IP2 Receptor in a Living Human Brain
2000 StandoutNobel
Understanding Adipocyte Differentiation
1998 Standout
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Down-Regulation of Prostaglandin E Receptors and Homologous Desensitization of Isolated Adipocytes
1983
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Nucleosidsynthesen, XVIII. Aminierung von Heterocyclen, II. Einfache neue Synthese von N6‐substituierten Adenosinen und Adeninen sowie ihrer 2‐Amino‐ und 2‐Hydroxyderivate
1976
Molecular Design of Prostaglandin Probes in Brain Research: High, Specific Binding to a Novel Prostacyclin Receptor in the Central Nervous System
2000 StandoutNobel
Asymmetric Transfer Hydrogenation of α, β-Acetylenic Ketones
1997 StandoutNobel
15-Deoxy-16-(m-tolyl)-17,18,19,20-tetranorisocarbacyclin: a simple TIC derivative with potent anti-apoptotic activity for neuronal cells
1999 StandoutNobel
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
1997 Standout
Triply-convergent synthesis of a homochiral 3,3-dimethyl, 15-cyclohexyl prostacyclin analog
1991
Selective Binding Site for [3H]Prostacyclin on Platelets
1979
Study on Efficient Synthetic Routes for 7-Fluoroprostaglandin F2α and 7-Fluoro-17,20-dimethyl-2,4-methyleneprostacyclin
1996
Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
2011 Standout
Identification of the prostacyclin receptor by radiation inactivation.
1984
International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.
1994 Standout
Pro-inflammatory and anti-inflammatory effects of the stable prostaglandin D2 analogue, ZK 118.182
1994
Evidence for high affinity prostacyclin binding sites in vascular tissue: Radioligand studies with a chemically stable analogue
1983
Characterization of Oxytocin Receptors on Isolated Rat Fat Cells
1975
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
Identification of the prostacyclin receptor by use of [15-3H1]19-(3-azidophenyl)-20-norisocarbacyclin, an irreversible specific photoaffinity probe.
1992 StandoutNobel
Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor
2001
Rapid Coupling of Methyl Iodide with Aryltributylstannanes Mediated by Palladium(0) Complexes: A General Protocol for the Synthesis of 11CH3‐Labeled PET Tracers
1997 StandoutNobel
Drospirenone for the Treatment of Hirsute Women with Polycystic Ovary Syndrome: A Clinical, Endocrinological, Metabolic Pilot Study
2004
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Heme-Containing Oxygenases
1996 Standout
Sexual Differentiation of the Central Nervous System
1981 StandoutScience
Different responsiveness of prostaglandin D2‐sensitive systems to prostaglandin D2 and its analogues
1985
A highly specific radioimmunological determination of sulprostone using antisera against two different haptens
1982
cDNA cloning of a mouse prostacyclin receptor. Multiple signaling pathways and expression in thymic medulla
1994
The Intramolecular Asymmetric Pauson−Khand Cyclization as a Novel and General Stereoselective Route to Benzindene Prostacyclins: Synthesis of UT-15 (Treprostinil)
2004
Characterization and regulation of prostaglandin and leukotriene receptors: An overview
1986
Solubilization of prostacyclin membrane receptors from human platelets
1989
The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes
1984 Nobel
(15 R)‐16‐m‐Tolyl‐17,18,19,20‐tetranorisocarbacyclin: A Stable Ligand with High Binding Affinity and Selectivity for a Prostacyclin Receptor in the Central Nervous System
1996 StandoutNobel
Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*
1980
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
On the multiplicity of platelet prostaglandin receptors
1984
Three-component coupling synthesis of prostaglandins. A simplified, general procedure
1990 StandoutNobel
Chemical Implications for Antitumor and Antiviral Prostaglandins: Reaction of Δ7-Prostaglandin A1 and Prostaglandin A1 Methyl Esters with Thiols
1997 StandoutNobel
Works of E. Schillinger being referenced
Characteristics of prostaglandin receptor sites in human uterine tissue.
1976
Drospirenone: a Novel Progestogen with Antimineralocorticoid and Antiandrogenic Activity
1995
Stable 9ß- or 11α-halogen-15-cyclohexyl-prostaglandins with high affinity to the PGD2-receptor
1988
Drospirenone: A novel progestogen with antimineralocorticoid and antiandrogenic activity
1995
Structure Activity Relationship of the Insulin-Like Effects of the Neurohypophysial Peptide Hormones
1972
Effects of prostacyclin analogues in in vivo tumor models.
1991
Receptor binding in various tissues of PGE2, PGF2α and sulprostone, a novel PGE2-derivative
1979
Prostaglandin I2 receptors in a particulate fraction of platelets of various species
1980
A tissue-selective prostaglandin E2 analog with potent antifertility effects
1977
EFFECTS OF PITUITARY HORMONES AND CORTICOSTERONE ON LIPOLYSIS IN HYPOPHYSECTOMIZED RATS
1974
Synthesis and pharmacological evaluation of 8α-estradiol derivatives
1982
Non-steroidal anti-inflammatories—XII
1982
Prostaglandin analogs. Part 9. Synthesis of a new chemically and metabolically stable prostacyclin analog with high and long-lasting oral activity
1986
Metabolic effects of N6-substituted adenosines in rats
1974
Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat
1986
ZK 110 841--a selective and potent prostaglandin D2 analogue.
1989
Identification and characterisation of a prostacyclin- like receptor in bovine coronary arteries using a specific and stable prostacyclin analogue, ciloprost, as radioactive ligand
1982
Pharmacological and cardiovascular properties of a hydantoin derivative, BW 245 C, with high affinity and selectivity for PGD2 receptors
1983
CHANGES IN INSULIN RECEPTOR CONCENTRATION IN RAT FAT CELLS FOLLOWING TREATMENT WITH THE GESTAGENS CLOMEGESTONE ACETATE AND CYPROTERONE ACETATE
1977